Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darryl Irwin

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Genes, Chromosomes & Cancer|September 23, 2008
Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanomaVanessa F Bonazzi, Darryl Irwin, Nicholas K Hayward
Cancer Metastasis Reviews|January 31, 2025
Minimally invasive biomarkers for triaging lung nodules-challenges and future perspectivesWaqar Ahmed Afridi, Samandra Hernandez Picos, Juliana Muller Bark, et al.
Lung Cancer (Amsterdam, Netherlands)|August 29, 2021
The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)Arutha Kulasinghe, Connor O'Leary, James Monkman, et al.
The Medical Journal of Australia|July 8, 2009
Evaluation of non-invasive prenatal RHD genotyping of the fetusCatherine A Hyland, Glenn J Gardener, Helen Davies, et al.
Breast Cancer Research and Treatment|September 9, 2021
Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survivalAthina Giannoudis, Alexander Sartori, Lee Eastoe, et al.
Carcinogenesis|January 25, 2024
Human papillomavirus (HPV) DNA methylation changes in HPV-associated head and neck cancerChameera Ekanayake Weeramange, Kai Dun Tang, Darryl Irwin, et al.
Cells|October 27, 2020
Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA AssayYassine Belloum, Melanie Janning, Malte Mohme, et al.
Heliyon|July 25, 2022
Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancerJoanna Kapeleris, Juliana Müller Bark, Shanon Ranjit, et al.
Plos One|September 20, 2017
Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX® HS, a new highly sensitive assay for the MassARRAY® SystemBobbie C Sutton, Ryan T Birse, Kevin Maggert, et al.
Scientific Reports|February 10, 2017
Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancerToni-Maree Rogers, Gisela Mir Arnau, Georgina L Ryland, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Genes, Chromosomes & Cancer|September 23, 2008
Identification of candidate tumor suppressor genes inactivated by promoter methylation in melanomaVanessa F Bonazzi, Darryl Irwin, Nicholas K Hayward
Cancer Metastasis Reviews|January 31, 2025
Minimally invasive biomarkers for triaging lung nodules-challenges and future perspectivesWaqar Ahmed Afridi, Samandra Hernandez Picos, Juliana Muller Bark, et al.
Lung Cancer (Amsterdam, Netherlands)|August 29, 2021
The identification of circulating tumour DNA using MassARRAY technology in non-small-cell lung cancer (NSCLC)Arutha Kulasinghe, Connor O'Leary, James Monkman, et al.
The Medical Journal of Australia|July 8, 2009
Evaluation of non-invasive prenatal RHD genotyping of the fetusCatherine A Hyland, Glenn J Gardener, Helen Davies, et al.
Breast Cancer Research and Treatment|September 9, 2021
Genomic profiling using the UltraSEEK panel identifies discordancy between paired primary and breast cancer brain metastases and an association with brain metastasis-free survivalAthina Giannoudis, Alexander Sartori, Lee Eastoe, et al.
Carcinogenesis|January 25, 2024
Human papillomavirus (HPV) DNA methylation changes in HPV-associated head and neck cancerChameera Ekanayake Weeramange, Kai Dun Tang, Darryl Irwin, et al.
Cells|October 27, 2020
Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA AssayYassine Belloum, Melanie Janning, Malte Mohme, et al.
Heliyon|July 25, 2022
Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancerJoanna Kapeleris, Juliana Müller Bark, Shanon Ranjit, et al.
Plos One|September 20, 2017
Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX® HS, a new highly sensitive assay for the MassARRAY® SystemBobbie C Sutton, Ryan T Birse, Kevin Maggert, et al.
Scientific Reports|February 10, 2017
Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancerToni-Maree Rogers, Gisela Mir Arnau, Georgina L Ryland, et al.
Pageof 2